A Study to Investigate VX-787 Given to Adult Volunteers Inoculated With Live Influenza Virus

Clinical trial NCT01561807 · COMPLETED

Trial details

NCT number: NCT01561807
Sponsor: Vertex Pharmaceuticals Incorporated
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Influenza Virus

Start date: 2012-03-01
Primary completion: 2012-10-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.